Concise Analysis of Biologics and Biosimilars World Markets

05-02-2014 PR NewswireComments (0)

Biosimilars

Also known as follow-on biologics or subsequent entry biologics (SEBs), biosimilars are to biologics what generics are to branded drugs; they lower healthcare expenditures. This report anticipates that the global biologic drugs market will jump to over ...

Read more on PR Newswire

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top